Cummings James F. has filed 18 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 3292 shares of Vaxart, Inc. ($VXRT) on March 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 28, 2026 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 3292 | $0.65 | 924,177.0000 | 240,069,844 | 0.35% | 0.00% |
| March 24, 2026 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 30551 | $0.69 | 927,469.0000 | 240,069,844 | 3.19% | 0.01% |
| March 18, 2026 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 6772 | $0.63 | 958,020.0000 | 240,069,844 | 0.70% | 0.00% |
| March 16, 2026 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Common Stock | 227000 | $0.00 | 964,792.0000 | 240,069,844 | 30.77% | 0.09% |
| March 16, 2026 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Stock Option (right to buy) | 455000 | $0.00 | 455,000.0000 | 240,069,844 | 9999.99% | 0.19% |
| Feb. 2, 2026 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 7965 | $0.61 | 737,792.0000 | 240,069,844 | 1.07% | 0.00% |
| March 28, 2025 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 3292 | $0.42 | 745,757.0000 | 227,949,245 | 0.44% | 0.00% |
| March 24, 2025 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 227,949,245 | 9999.99% | 0.02% |
| March 24, 2025 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Stock Option (right to buy) | 610000 | $0.00 | 610,000.0000 | 227,949,245 | 9999.99% | 0.27% |
| March 24, 2025 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Common Stock | 406000 | $0.00 | 749,049.0000 | 227,949,245 | 118.35% | 0.18% |
| March 18, 2025 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 6772 | $0.57 | 343,049.0000 | 227,949,245 | 1.94% | 0.00% |
| March 28, 2023 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 3267 | $0.75 | 349,821.0000 | 0 | 0.93% | 0.00% |
| Feb. 2, 2025 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 7964 | $0.68 | 318,837.0000 | 0 | 2.44% | 0.00% |
| March 28, 2024 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 3292 | $1.30 | 326,801.0000 | 0 | 1.00% | 0.00% |
| March 18, 2024 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Stock Option (right to buy) | 410000 | $0.00 | 410,000.0000 | 0 | 9999.99% | 0.00% |
| March 18, 2024 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | A | Common Stock | 90000 | $0.00 | 330,093.0000 | 0 | 37.49% | 0.00% |
| Feb. 2, 2024 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 7965 | $1.20 | 240,093.0000 | 0 | 3.21% | 0.00% |
| Dec. 8, 2023 | Vaxart, Inc. | $VXRT | Cummings James F. | Chief Medical Officer | F | Common Stock | 31409 | $0.71 | 248,058.0000 | 0 | 11.24% | 0.00% |